ORTHOPEDIATRICS CORP
Company Stats
- Market Cap
- $581.5M
- as of Sep 30, 2026
- Shares Outstanding
- 26.1M
- Free Float
- 76.2%
Income Statement
- Revenue
- $236.3M
- Operating Income
- -$39.2M
- Net Income
- -$39.6M
- EBITDA
- -$18.1M
- Non-cash Impairment
- $1.9M
- Revenue Growth, 3Y
- 24.6%
- FCF Margin, 3Y Avg
- -18.8%
- FCF Margin, Worst Year
- -29.5%
Cash Flow
- Free Cash Flow
- -$16.0M
- FCF Yield
- -2.7%
- Owner FCF Yield
- -5.8%
Balance Sheet
- Cash & Equivalents
- $19.6M
Returns & Capital
- SBC, 3Y Avg
- $14.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $236.3M | -$16.0M | -6.8% |
| FY2024 | $204.7M | -$41.3M | -20.2% |
| FY2023 | $148.7M | -$43.9M | -29.5% |
| FY2022 | $122.3M | -$31.8M | -26.0% |
| FY2021 | $98.0M | -$21.2M | -21.6% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 30, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back